![Dominic Borie](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dominic Borie
Chief Tech/Sci/R&D Officer at
CUE BIOPHARMA, INC.
Net worth: 994 140 $ as of 2026-06-29
Profile
Dominic Borie is Chief Medical Officer, Head-Research & Development at Cue Biopharma, Inc. since 2026.
Former roles include President-Research & Development at Kyverna Therapeutics, Inc. from 2022 to 2025, VP, Head-External Research & Development at Horizon Therapeutics Ltd. (Ireland), Director-Transplantation Immunology Laboratory at Stanford University, Senior Medical Director at Genentech, Inc., Medical Director at Amgen, Inc., and Executive Director at Allogene Therapeutics, Inc. Education includes a doctorate from The University of Texas at Austin and an undergraduate degree from North Carolina State University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
CUE BIOPHARMA, INC. 0.75% | 2026-07-12 | 31,500 ( 0.75% ) | 994 140 $ | 2026-06-29 |
Dominic Borie active positions
| Companies | Position | Start |
|---|---|---|
| CUE BIOPHARMA, INC. | Chief Tech/Sci/R&D Officer | 2026-07-12 |
Former positions of Dominic Borie
| Companies | Position | End |
|---|---|---|
| KYVERNA THERAPEUTICS, INC. | Chief Executive Officer | 2022-10-12 |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
| AMGEN INC. | Chief Tech/Sci/R&D Officer | - |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | - |
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Corporate Officer/Principal | - |
Training of Dominic Borie
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
38
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Horizon Therapeutics Ltd. (Ireland)
 Horizon Therapeutics Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Discovers, develops and manufactures pharmaceuticals for autoimmune & inflammatory diseases | Health Technology |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Texas at Austin
 The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
North Carolina State University
 North Carolina State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cue Biopharma, Inc.
 Cue Biopharma, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
Allogene Therapeutics, Inc.
 Allogene Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage immuno-oncology | Health Technology |
Kyverna Therapeutics, Inc.
 Kyverna Therapeutics, Inc. BiotechnologyHealth Technology Operates as a cell therapy company which develops treatments and potential cures for serious autoimmune diseases | Health Technology |
- Stock Market
- Insiders
- Dominic Borie
